Special Symposium

Is there clinical evidence to support the link between PARPi use and a negative impact on OS?

Session Name
How to interpret overall survival data with PARP inhibitors (ID 3)
Speakers
  • Jonathan A. Ledermann (London, London, United Kingdom)
Date
Thu, 23.02.2023
Time
10:15 - 11:35
Room
Auditorium 113
Duration
15 Minutes